[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.136.184. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 254
Citations 0
Correction
May 2017

Error in Byline and Results Section and Other Typographical Errors

JAMA Dermatol. 2017;153(5):479. doi:10.1001/jamadermatol.2017.0712

In the Original Investigation titled “Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial,”1 published online on February 15, 2017, there was an author's missing middle initial in the byline, an error in the Results section in the abstract and text, and other minor typographical errors throughout the text. This article was corrected online.

References
1.
Tacastacas  JD, Chan  DV, Carlson  S,  et al.  Evaluation of O6-benzylguanine-potentiated topical carmustine for mycosis fungoides: a phase 1-2 clinical trial  [published online February 15, 2017].  JAMA Dermatol. doi:10.1001/jamadermatol.2016.5793PubMedGoogle Scholar
×